Equities research analysts at Zacks Research dropped their FY2026 earnings estimates for Keysight Technologies in a research report issued on Tuesday, October 22nd. Zacks Research analyst R.
Heidelberg Pharma AG (FSE: HPHA), a clinical-stage developer of innovative Antibody Drug Conjugates (ADCs), announces it will present its ADC candidates and ADC technology platforms at ...